EP3050880
QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.9.2014EP published:
19.6.2019EP application number:
14849754.8
EPO information:
European Patent Register
Max expiry date:
27.9.2034
Title:
QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER
Timeline
Today
28.9.2014EP application
19.6.2019EP Publication
Owner
Name:
Chia Tai Tianqing Pharmaceutical Group Co.,LtdAddress:
No. 369 Yuzhou South Road Haizhou District, 222062, Lianyungang, Jiangsu, CN
Name:
Centaurus BioPharma Co., Ltd.Address:
No.16 Building No.3 Minzhuang Road Haidian District, 100195, Beijing, CN
Name:
Lianyungang Runzhong Pharmaceutical Co., Ltd.Address:
No. 16 Jinqiao Road Dapu Industry Park Lianyungang Economy and Technology Development Zone, 222069, Lianyungang, Jiangsu, CN
Inventor
Name:
XIAO, DengmingAddress:
Beijing, CN
Name:
ZHU, YanAddress:
Beijing, CN
Name:
HU, YuandongAddress:
Beijing, CN
Name:
WANG, HutingAddress:
Beijing, CN
Name:
LI, JijunAddress:
Beijing, CN
Name:
PENG, YongAddress:
Beijing, CN
Name:
ZHANG, HuiAddress:
Beijing, CN
Name:
LUO, HongAddress:
Beijing, CN
Name:
KONG, FanshengAddress:
Beijing, CN
Name:
HAN, YongxinAddress:
Beijing, CN
Priority
Number:
201310452885Date:
28.9.2013Country:
CN
Classification
Categories:
C07D 401/12, C07D 401/14, C07D 403/12, C07D 405/14, A61K 31/517, A61K 31/5377, A61P 35/00